NCT06975059 · Weill Medical College of Cornell University
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients
What this study is about
Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational feedback that can potentially help gait difficulties experienced by Parkinson's patients.
View original scientific description
Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational feedback that can potentially help gait difficulties experienced by Parkinson's patients.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Male or female ≥ 18 years of age.
- A diagnosis of Parkinson's disease
- Able to give written informed consent (as determined by the investigator)
- Can converse in English and read and perform all study activities
- Has willingness and ability to comply with study requirements
Exclusion criteria
- Diagnosis of an atypical parkinsonism syndrome, drug-induced parkinsonism, essential tremor, or other diagnoses that explain movement symptoms other than PD
- A diagnosis of significant CNS disease other than PD such as stroke, multiple sclerosis, epilepsy
- Persons with disorders other than PD significantly affecting gait as determined by the investigator
- History of MRI brain scan indicative of clinically significant abnormality as determined by the investigator
- Inability to wear interventional device
- Unable to ambulate independently at least with assistive walking device but without additional person assistance
- Pregnant or planning pregnancy within study timeframe
- Montreal Cognitive Assessment (MoCA) score \< 22 at screening
- Resides in a nursing home or assisted care facility Healthy Controls: Inclusion Criteria:
- Male or female ≥ 18 years of age.
- No neurological disease or other significant gait impairment as deemed by the study investigator
Where
- New York, New York
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Oct 1, 2025 · Source of record for eligibility and locations